What is Urogenital Menopausal Syndrome? When a woman advances in the premenopausal and menopausal period, the level of sex hormones, especially those of the estrogen type, decreases.
This decrease in estrogen hormones leads to significant changes in the genital area (vagina, vulva) and lower urinary system (bladder, urethra).
These changes affecting over 50% of menopausal women include:
How is menopausal genitourinary syndrome treated?
This pixel energy applied to the tissues of the genital area penetrates and improves the quality of the mucosa or skin by stimulating the collagen and elastin synthesis process and by increasing the vasculaturization.
Treated tissues will be firmer, more elastic, more resistant.
This remodeling process increases the elasticity and lubrication of the genital mucosa resulting in the disappearance / improvement of spontaneous discomfort or the discomfort felt during sexual intercourse. By reshaping the vaginal wall, vaginal rejuvenation improves mild / moderate urinary incontinence.
Studies show that by increasing the quality of the vaginal mucosa and stimulating local immune processes, vaginal rejuvenation has a positive role including for chronic vaginosis and HPV infection.